A detailed history of Strs Ohio transactions in Aadi Bioscience, Inc. stock. As of the latest transaction made, Strs Ohio holds 155,500 shares of AADI stock, worth $227,030. This represents 0.0% of its overall portfolio holdings.

Number of Shares
155,500
Previous 6,600 2256.06%
Holding current value
$227,030
Previous $13,000 2692.31%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024

BUY
$1.59 - $2.44 $236,751 - $363,316
148,900 Added 2256.06%
155,500 $363,000
Q4 2023

Jan 30, 2024

BUY
$1.97 - $5.41 $9,653 - $26,509
4,900 Added 288.24%
6,600 $13,000
Q3 2023

Oct 26, 2023

BUY
$4.84 - $7.13 $8,228 - $12,121
1,700 New
1,700 $8,000
Q3 2022

Oct 27, 2022

SELL
$12.03 - $14.22 $10,827 - $12,798
-900 Reduced 26.47%
2,500 $35,000
Q2 2022

Jul 25, 2022

BUY
$11.57 - $17.92 $39,338 - $60,928
3,400 New
3,400 $41,000

Others Institutions Holding AADI

About Aadi Bioscience, Inc.


  • Ticker AADI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 21,016,800
  • Market Cap $30.7M
  • Description
  • Aadi Bioscience, Inc., a clinical-stage biopharmaceutical company, engages in developing and commercializing precision therapies for genetically defined cancers with alterations in mTOR pathway genes. Its lead drug candidate, FYARRO is a form of sirolimus bound to albumin. Aadi is evaluating FYARRO in cancers with known mTOR pathway activation, ...
More about AADI
Track This Portfolio

Track Strs Ohio Portfolio

Follow Strs Ohio and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Strs Ohio, based on Form 13F filings with the SEC.

News

Stay updated on Strs Ohio with notifications on news.